Metropolis Healthcare Ltd

Metropolis Healt Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Metropolis Healthcare Ltd

₹ 2,037 2.98%
22 Jul 4:01 p.m.
metropolisindia.com BSE: 542650 NSE: METROPOLIS
About

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

Key Points

Leading Diagnostics company[1] Metropolis Healthcare Ltd is the second largest Diagnostic company in India and the largest player in Western and Southern India.

Website BSE NSE
  • Market Cap ₹ 10,458 Cr.
  • Current Price ₹ 2,037
  • High / Low ₹ 2,121 / 1,296
  • Stock P/E 90.2
  • Book Value ₹ 201
  • Dividend Yield 0.39 %
  • ROCE 14.8 %
  • ROE 11.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 10.1 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
281 313 287 272 285 257 280 265 264 256 285 269 292
186 216 202 205 216 196 205 199 197 198 218 211 218
Operating Profit 95 98 85 67 69 61 75 66 68 58 67 59 74
OPM % 34% 31% 30% 25% 24% 24% 27% 25% 26% 23% 24% 22% 25%
2 20 4 2 6 2 3 7 9 3 2 5 2
Interest 3 6 3 5 6 8 7 6 6 6 6 5 6
Depreciation 14 13 14 16 17 20 20 22 22 20 21 24 25
Profit before tax 81 99 72 49 52 36 51 44 48 35 42 35 45
Tax % 24% 27% 25% 25% 28% 20% 25% 26% 17% 26% 26% 23% 29%
61 72 54 36 37 28 38 33 40 26 31 27 32
EPS in Rs 12.02 14.15 10.51 7.11 7.27 5.55 7.39 6.41 7.80 5.10 6.11 5.21 6.20
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
223 254 349 405 485 581 665 961 1,157 1,066 1,103
159 183 263 289 348 434 489 677 833 792 845
Operating Profit 64 71 86 115 137 148 176 285 324 274 258
OPM % 29% 28% 25% 29% 28% 25% 26% 30% 28% 26% 23%
15 6 39 30 15 20 5 12 32 21 12
Interest 2 2 1 2 3 3 10 11 25 31 22
Depreciation 8 10 12 12 14 15 31 44 60 85 91
Profit before tax 69 65 112 131 135 149 140 242 272 179 157
Tax % 33% 33% 32% 33% 29% 32% 20% 25% 27% 22% 26%
46 43 76 88 96 101 112 183 200 139 116
EPS in Rs 47.12 43.64 79.59 92.21 100.34 20.22 22.13 35.73 38.99 27.13 22.62
Dividend Payout % 3% -0% 101% 57% -0% 66% 36% 22% 21% 29% -0%
Compounded Sales Growth
10 Years: 17%
5 Years: 14%
3 Years: 5%
TTM: 4%
Compounded Profit Growth
10 Years: 10%
5 Years: 3%
3 Years: -14%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: 14%
3 Years: -10%
1 Year: 46%
Return on Equity
10 Years: 22%
5 Years: 21%
3 Years: 17%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 10 10 10 10 10 10 10 10 10 10 10
Reserves 254 296 233 258 354 405 502 655 829 926 1,021
16 10 4 -0 -0 17 54 111 377 268 195
33 35 95 170 76 95 122 163 242 230 247
Total Liabilities 313 351 341 438 440 528 688 939 1,459 1,434 1,473
83 84 92 152 157 163 216 307 1,005 1,066 1,120
CWIP -0 -0 -0 -0 -0 6 3 -0 6 20 -0
Investments 148 175 120 143 98 135 130 12 50 50 90
82 92 129 143 185 224 340 620 398 299 263
Total Assets 313 351 341 438 440 528 688 939 1,459 1,434 1,473

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
52 43 75 77 74 56 156 236 244 238 269
-39 -36 101 -67 19 -4 -51 59 -736 47 -81
-10 -10 -165 -17 -82 -64 -46 -31 172 -288 -183
Net Cash Flow 3 -3 11 -6 12 -12 59 264 -320 -3 5

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 50 60 50 56 62 74 68 50 44 43 43
Inventory Days 49 50 42 35 49 52 38 57 66 64 56
Days Payable 64 71 84 93 87 95 155 143 131 133 155
Cash Conversion Cycle 34 38 7 -1 24 31 -48 -36 -22 -26 -56
Working Capital Days 60 48 12 -47 43 57 29 16 23 24 28
ROCE % 22% 37% 50% 43% 38% 35% 38% 28% 17% 15%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
50.33% 49.50% 49.79% 49.79% 49.76% 49.76% 49.75% 49.75% 49.75% 49.74% 49.67% 49.62%
30.72% 30.06% 21.91% 23.20% 25.57% 23.86% 25.67% 25.66% 24.29% 21.66% 18.90% 18.25%
12.26% 11.35% 16.20% 14.50% 12.38% 13.30% 13.64% 14.89% 16.86% 20.73% 24.86% 27.42%
6.69% 9.09% 12.11% 12.52% 12.30% 13.09% 10.94% 9.69% 9.10% 7.87% 6.57% 4.69%
No. of Shareholders 43,55264,16879,89586,40490,09091,45284,26989,69286,24979,87868,28358,108

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls